Data Collective Iv Gp, LLC Recursion Pharmaceuticals, Inc. Transaction History
Data Collective Iv Gp, LLC
- $114 Million
- Q4 2024
A detailed history of Data Collective Iv Gp, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Data Collective Iv Gp, LLC holds 5,941,120 shares of RXRX stock, worth $36.7 Million. This represents 35.37% of its overall portfolio holdings.
Number of Shares
5,941,120
Previous 5,941,120
-0.0%
Holding current value
$36.7 Million
Previous $39.2 Million
2.58%
% of portfolio
35.37%
Previous 36.64%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
341Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$210 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$200 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$153 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$107 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$90.5 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.11B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...